Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zist Orchid Pharmed is a specialized biotechnology company based in Tehran, Iran, and serves as a core manufacturing and development arm of the Orchid Pharmed Group. The company is dedicated to the production of high-value biosimilars and biological therapeutics, addressing critical needs in oncology, neurology, and reproductive health. Its commercial portfolio includes prominent products such as Zytux (a rituximab biosimilar) and PegaGen (a pegfilgrastim biosimilar), which are utilized in the treatment of various cancers and autoimmune conditions. As a knowledge-based enterprise, Zist Orchid Pharmed integrates advanced manufacturing capabilities with rigorous quality control to meet international standards. The company plays a pivotal role in the Iranian healthcare sector by increasing the accessibility of complex biologics and is actively expanding its presence in regional export markets. Through strategic partnerships and internal research, it continues to develop a robust pipeline of recombinant proteins and monoclonal antibodies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zist orchid pharmed.